Parallel Advisors’s Kindred Healthcare KND Stock Holding History

Parallel Advisors’s Portfolio KND Stock Details KND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-195	Closed	-$2K	–	2321
2017 Q2	$2K	Buy	+195	New	+$1.92K	﹤0.01%	1941

Other funds holding KND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Parallel Advisors's KND Position: Q3 2017 in Review

Parallel Advisors sold out of Kindred Healthcare (KND) in Q3 2017, closing a stake of 195 shares — an estimated $2K sold.

Parallel Advisors first reported a position in KND in Q2 2017 and held it in 1 quarter. The position peaked at $2K in Q2 2017. 168 funds tracked by Wall St. Rank hold KND as of Q3 2017.

Parallel Advisors reported no remaining Kindred Healthcare position as of Q3 2017 after selling out during the quarter.
Parallel Advisors sold 195 Kindred Healthcare shares in Q3 2017, an estimated $2K.
Parallel Advisors first reported a position in Kindred Healthcare in Q2 2017 and held it in 1 quarter.
Parallel Advisors's Kindred Healthcare position peaked at $2K in Q2 2017.
168 funds tracked by Wall St. Rank held Kindred Healthcare as of Q3 2017.

Based on Parallel Advisors's 13F filing for Q3 2017, filed 14 Nov 2017.